Novavax (NVAX) Revenue (2010 - 2026)
Novavax (NVAX) reported Revenue of $56.7 million for Q2 2026, down 76.3% from $239.24 million a year earlier and down 59.4% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Revenue (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Novavax's Revenue came in at $413.8 million, down 61.6% year-over-year; for FY2025, it was $1.12 billion, up 64.7% from FY2024.
- Revenue has a five-year compound annual growth rate of 18.8% (FY2020 to FY2025).
- By year, Revenue came in at $682.16 million in FY2024 (-30.7%), $983.71 million in FY2023 (-50.4%), $1.98 billion in FY2022 (+72.9%) and $1.15 billion in FY2021 (+141.0%).
- The Q2 2026 figure ranks as the lowest quarterly Revenue since Q2 2020.
- Year over year, Revenue gained in two of the last eight quarters, with growth averaging 42.2%.
- The high point for year-over-year Revenue in five years was Q1 2025 (growth of 610.3%); the low point was Q1 2023 (a decline of 88.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $139.51 million (Q1 2026), $147.14 million (Q4 2025) and $70.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Novavax | 1.78 Bn | -1.22 Bn | 42.45 Mn | 56.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.70 Mn |
| Mar 31, 2026 | 139.51 Mn |
| Dec 31, 2025 | 147.14 Mn |
| Sep 30, 2025 | 70.45 Mn |
| Jun 30, 2025 | 239.24 Mn |
| Mar 31, 2025 | 666.66 Mn |
| Dec 31, 2024 | 88.31 Mn |
| Sep 30, 2024 | 84.51 Mn |
| Jun 30, 2024 | 415.48 Mn |
| Mar 31, 2024 | 93.86 Mn |
| Dec 31, 2023 | 291.34 Mn |
| Sep 30, 2023 | 186.99 Mn |
| Jun 30, 2023 | 424.43 Mn |
| Mar 31, 2023 | 80.95 Mn |
| Dec 31, 2022 | 357.40 Mn |
| Sep 30, 2022 | 734.58 Mn |
| Jun 30, 2022 | 185.93 Mn |
| Mar 31, 2022 | 703.97 Mn |
| Dec 31, 2021 | 222.20 Mn |
| Sep 30, 2021 | 178.84 Mn |
API Access
Novavax Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();